zk1008708.htm


SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 
F O R M 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR
15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of August 2010
 
ELTEK LTD.
(Name of Registrant)
 
Sgoola Industrial Zone, Petach Tikva, Israel
(Address of Principal Executive Office)
 
    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F x Form 40-F o
 
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
 
    Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
 
    Indicate by check mark whether by furnishing the information contained in this Form, the registrant is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
 
Yes o No x
 
 
    If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- ____________
 
This Form 6-K is being incorporated by reference into the Registrant’s Form S-8 Registration Statements File Nos. 333-12012 and 333-123559.
 
 
 

 
 
SIGNATURES
 
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
ELTEK LTD.
(Registrant)
 
       
 
By:
/s/ Amnon Shemer  
    Amnon Shemer  
   
Chief Financial Officer
 
       
 
Date: August 24, 2010
 
 
 
 

 
 
 
 Press Release
 
Eltek Reports Second Quarter 2010 Financial Results
 
PETACH-TIKVA, Israel, August 24, 2010 (NASDAQ:ELTK) - Eltek Ltd., the leading Israeli manufacturer of advanced flex-rigid circuitry solutions, announced today its financial results for the quarter ended June 30, 2010.

Second Quarter 2010:

Revenues for the quarter ended June 30, 2010 were $9.0 million, an increase of 6% from the revenues of $8.4 million recorded in the second quarter of 2009. 

Gross profit for the second quarter of 2010 was $1.3 million (14% of revenues), similar to the gross profit of $1.3 million (16% of revenues) in the second quarter of 2009. The decrease in gross margins is primarily attributable to the lower exchange rates of the US dollar and the Euro compared to the NIS, which was partially offset by the increase in revenues.

Operating loss for the second quarter of 2010 was $203,000 compared with an operating loss of $118,000 in the second quarter of 2009.

Net loss for the second quarter of 2010 was $509,000 or ($0.08) per fully diluted share, compared with a net loss of $183,000 or ($0.03) per fully diluted share in the second quarter of 2009.

 
 

 


 
First six months of 2010:

Revenues for the first six months ended June 30, 2010 were $18.6 million, an increase of 4% from revenues of $17.9 million recorded in the first six months of 2009. 

Gross profit for the first six months of 2010 was $2.3 million (12% of revenues), compared to gross profit of $3 million (17% of revenues) in the first six months of 2009.

Operating loss for the first six months of 2010 was $762,000 compared with an operating profit of $47,000 in the first six months of 2009.

Net loss for the first six months of 2010 was $1.2 million or ($0.13) per fully diluted share, compared with a net loss of $78,000, or ($0.01) per fully diluted share in the first six months of 2009.

Due to ongoing losses in recent periods, the amount of the Company’s shareholders’ equity is below the required level under the financial covenants with two of its banks. Although compliance with the financial covenants will next be measured based on the Company’s audited financial statements as of December 31, 2010, and the Company continues with its efforts to increase revenues and improve production efficiency, the losses incurred in the first six months of 2010 may likely result in non compliance at year end. As a result, accounting standards require the Company to re-classify at this time its bank debt in the amount of $ 1.4 million from long term to short term. Based on past experience, where the Company was granted waivers from these banks in similar situations of non-compliance with financial covenants, the Company intends to re-apply, if necessary, for a waiver from the banks. There can be no assurance that the banks will grant the requested waivers. Failure to successfully obtain the waivers or additional capital may have a material adverse effect on the Company’s business, results of operations and financial position.
 
 
 

 
 
 
In addition to the Company’s efforts to return to profitability, it is actively seeking alternatives to strengthen its capital, either from its shareholders and/or other sources.

EBITDA:

In the quarter ended June 30, 2010, Eltek had EBITDA of $465,000 compared with an EBITDA of $411,000 in the second quarter of 2009. In the first six months of 2010, Eltek had EBITDA of $482,000 compared with EBITDA of $1.1 million in the same period in 2009.

ELTEK uses EBITDA as a non-GAAP financial performance measurement. EBITDA is calculated by adding back to net income interest, taxes, depreciation and amortization. EBITDA is provided to investors to complement results provided in accordance with GAAP, as management believes the measure helps illustrate underlying operating trends in the Company's business and uses the measure to establish internal budgets and goals, manage the business and evaluate performance. EBITDA should not be considered in isolation or as a substitute for comparable measures calculated and presented in accordance with GAAP. Reconciliation between the company's results on a GAAP and non-GAAP basis is provided in a table immediately following the Consolidated Statement of Operations
 
Management Comments:

Arieh Reichart, President and Chief Executive Officer of Eltek commented: "Our disappointment with this quarter’s results is mainly due to our revenues, which were lower than our expectations and internal forecasts. We are working hard to improve our sales performance and hope to see improvement in the future. On the other hand, we have continued with our manufacturing efficiency improvements program according to plan, which is showing positive results. This will enable us to provide complicated products within shorter lead times, which will result in higher margins and improved operating results in future periods."
 
 
 

 

 
Amnon Shemer, CFO of Eltek, added: “Our net loss was impacted by higher finance expenses, mainly due to two major reasons: the sharp decline in the exchange rate of the Euro compared to the NIS, which resulted in a decrease in the value of our European customers’ debt to us, and by a net loss recorded from hedging transactions. Accounting standards require us to re-evaluate the value of our open hedging transactions for future periods as of the balance sheet date. As the dollar exchange rate on June 30, 2010 was higher than the effective exchange rate on these forward transactions, we had to record a loss, even though the actual results on these transactions may differ at the time of exercise.”
 
About the Company
Eltek is Israel's leading manufacturer of printed circuit boards, the core circuitry of most electronic devices. It specializes in the complex high-end of PCB manufacturing, i.e., HDI, multilayered and flex-rigid boards. Eltek's technologically advanced circuitry solutions are used in today's increasingly sophisticated and compact electronic products. For more information, visit Eltek's web site at www.eltekglobal.com.
 
 
 
 

 
 
 
Forward Looking Statement:
Certain matters discussed in this news release are forward-looking statements that involve a number of risks and uncertainties including, but not limited to statements regarding expected results in future quarters, risks in product and technology development and rapid technological change, product demand, the impact of competitive products and pricing, market acceptance, the sales cycle, changing economic conditions and other risk factors detailed in the Company's Annual Report on Form 20-F and other filings with the United States Securities and Exchange Commission.
 
 
 

 
 
Eltek  ltd.
Unaudited Consolidated Statements of Operations
(In thousands US$, except per share data)
 
   
Three months ended
   
Six months ended
   
Year ended
 
   
June 30,
   
June 30,
   
December 31,
 
   
2010
   
2009
   
2010
   
2009
   
2009
 
                               
Revenues
    8,961       8,427       18,593       17,919       36,442  
Costs of revenues
    (7,680 )     (7,084 )     (16,273 )     (14,953 )     (30,882 )
                                         
Gross profit
    1,281       1,343       2,320       2,966       5,560  
                                         
Research and development income, net
    0       0       0       0       0  
                                         
Selling, general and administrative expenses
    (1,484 )     (1,461 )     (3,082 )     (2,919 )     (6,016 )
Operating loss
    (203 )     (118 )     (762 )     47       (456 )
                                         
Financial expenses, net
    (317 )     (120 )     (486 )     (144 )     (424 )
                                         
Other income, net
    2       0       0       4       4  
                                         
Loss before income tax expenses
    (518 )     (238 )     (1,248 )     (93 )     (876 )
                                         
Income tax expenses, net
    (5 )     (8 )     (11 )     (44 )     (34 )
                                         
Net loss
    (523 )     (246 )     (1,259 )     (137 )     (910 )
                                         
Net profit (loss) attributable to non controlling shareholders
    14       63       68       59       30  
                                         
Net loss attributable to shareholders
    (509 )     (183 )     (1,191 )     (78 )     (880 )
                                         
Earning per share
                                       
                                         
Basic net loss per ordinary share
    (0.08 )     (0.03 )     (0.13 )     (0.01 )     (0.13 )
                                         
Diluted net loss per ordinary share
    (0.08 )     (0.03 )     (0.13 )     (0.01 )     (0.13 )
                                         
Weighted average number of ordinary shares
                                       
used to compute basic net loss per
                                       
ordinary share (in thousands)
    6,610       6,610       6,610       6,610       6,610  
                                         
Weighted average number of ordinary shares
                                       
used to compute diluted net loss per
                                       
ordinary share (in thousands)
    6,610       6,610       6,610       6,610       6,610  
 
 
 
 

 
 
Eltek  ltd.
Unaudited Consolidated Balance Sheets
(In thousands US$)
 
   
June 30,
   
December 31,
 
   
2010
   
2009
   
2009
 
Assets
                 
                   
Current assets
                 
Cash and cash equivalents
    1,134       2,511       1,258  
Receivables:   Trade, net of provision for doubtful accounts
    7,527       7,030       6,932  
                     Other
    221       298       222  
Inventories
    3,989       4,073       3,938  
Prepaid expenses
    161       201       241  
                         
Total current assets
    13,032       14,113       12,591  
                         
Assets held for employees' severance benefits
    1,428       1,293       1,432  
                         
Fixed assets, less accumulated depreciation
    8,096       9,246       9,175  
                         
Goodwill
    488       561       573  
                         
Total assets
    23,044       25,213       23,771  
                         
Liabilities and Shareholder's equity
                       
                         
Current liabilities
                       
Short-term credit and current maturities of long-term debts
    7,828       5,746       5,638  
Accounts payable: Trade
    5,765       5,007       4,666  
                            Related parties
    840       575       713  
                            Other
    3,506       3,768       3,558  
                         
Total current liabilities
    17,939       15,096       14,575  
                         
Long-term liabilities
                       
Long term debt, excluding current maturities
    73       3,048       2,617  
Employee severance benefits
    1,456       1,346       1,440  
                         
Total long-term liabilities
    1,529       4,394       4,057  
                         
Equity
                       
Ordinary shares, NIS 0.6  par value authorized 50,000,000
shares, issued and outstanding 6,610,107 as of September 30, 2009,
6,610,107 as of September 30, 2008 and 6,610,107 as of December 31, 2008
    1,384       1,384       1,384  
Additional paid-in capital
    14,328       14,328       14,328  
Cumulative translation adjustment related to change in reporting currency
    2,553       2,428       2,635  
Cumulative foreign currency translation adjustments
    127       335       309  
Capital reserve
    695       695       695  
Accumulated deficit
    (15,712 )     (13,720 )     (14,522 )
Shareholders' equity
    3,375       5,450       4,829  
Non controlling interest
    201       273       310  
Total equity
    3,576       5,723       5,139  
                         
Total liabilities and shareholders' equity
    23,044       25,213       23,771  
 
 
 

 
 
Non-GAAP EBITDA Reconcilliations
 
Three months ended
   
Six months ended
   
Year ended
 
   
June 30,
   
June 30,
   
December 31,
 
   
2010
   
2009
   
2010
   
2009
   
2009
 
   
Unaudited
 
                               
GAAP net loss
    (509 )     (183 )     (1,191 )     (78 )     (880 )
Add back items:
                                       
                                         
Financial  expenses, net
    317       120       486       144       424  
Tax expenses (income)
    5       8       11       44       34  
Depreciation
    651       466       1,175       947       2,030  
Adjusted EBITDA
    465       411       482       1,057       1,608